The proposed Modification No. M0010 to Contract No. CW94739 with Ramsell Corporation aims to increase the not-to-exceed (NTE) amount of the contract by $3,000,000, raising the total ceiling to $13,500,000. This increase is necessary for Ramsell to continue providing a Pharmacy Benefit Management System (PBMS) for various health programs under DC Health, including the Aids Drug Assistance Program and the Medication Assisted Therapy program. The modification addresses unforeseen costs, particularly due to a projected rise in drug expenditures linked to higher client usage and escalating drug prices. The contract modification will be structured as a firm-fixed price with a cost reimbursement component, covering the period from January 18, 2025, to January 17, 2026.

The bill also includes a revised price schedule detailing the specific costs associated with the services provided under the contract, ensuring that the total not-to-exceed amount for both option periods is set at $13,500,000. The modification maintains all terms and conditions of the original contract, with the exception of the specified adjustments. The Office of Contracting and Procurement has confirmed that Ramsell meets all legal and financial requirements to continue its services, with no pending legal claims against the District.